Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 08, 2023 07:45 ET | Source: Profound Medical Corp.

Profound Medical to Participate in the Stifel 2023 Healthcare Conference

TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
November 03, 2023 08:00 ET | Source: Profound Medical Corp.

Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting

TORONTO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
November 02, 2023 16:05 ET | Source: Profound Medical Corp.

Profound Medical Announces Third Quarter 2023 Financial Results

TORONTO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
October 19, 2023 16:30 ET | Source: Profound Medical Corp.

Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow

TORONTO, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
October 10, 2023 16:30 ET | Source: Profound Medical Corp.

Profound Medical 2023 Virtual Analyst & Investor Day Agenda

TORONTO, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
September 25, 2023 16:05 ET | Source: Profound Medical Corp.

Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost

TORONTO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
September 21, 2023 08:00 ET | Source: Profound Medical Corp.

Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13

TORONTO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
September 19, 2023 16:45 ET | Source: Profound Medical Corp.

Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference

TORONTO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
September 06, 2023 19:23 ET | Source: Profound Medical Corp.

Profound Medical Announces At-the-Market Offering of up to US$30,000,000

TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) announces that it has established an at-the-market equity program (the “ATM...
August 09, 2023 16:05 ET | Source: Profound Medical Corp.

Profound Medical Announces Second Quarter 2023 Financial Results

TORONTO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...